Many research studies show, pain is a significant source of suffering for many people and seriously affects their quality of life. Treatment of these patients is a great challenge and requires special approaches.

SMi is proud to present the return of 16th Annual Pain Therapeutics to London, UK on 23-24 of May 2016. Through a series of interactive presentations and panel discussions, the event will introduce the insights from key industry leaders, outlining the current activities, key issues and trends in pain medicine. This event will bring highlights of research and development in the pain relief field as well as new models and innovation of overcoming issues in the niche market.

For more info visit:

SMi proudly presents its inaugural event of the premier Pre-Filled Syringes series to San Diego in June 2016!

The prefilled syringes (PFS) market is poised to account for exponential growth and account for $6 billion revenue by the end of 2020.* The market has witnessed continual advancements in device design with enhanced safety and usability by patients through human factor engineering. Nonetheless, challenges surrounding biologic drug stability, manufacturing and competition from other drug delivery technologies remain key concerns amongst pharma and medical device manufacturers.

Emulating on SMi’s successful PFS series, we are bringing this must-attend event to the West Coast, where we will focus more on the innovative technologies. Join us today to discuss with your industry colleagues to accelerate PFS development!

For more info visit:

SMi is proud to announce the return of the 11th annual ADMET conference 2016 in London!

ADME and toxicology testing are one of the most important research activities related to new drug discovery. Ensuring a good ADMET study will accelerate approval and therefore commercialization of your drug product – and hence pharmacokinetics remain at the forefront of drug formulation and development
Since the pharmaceutical and biotechnology companies are utilising innovative technologies, ADME and toxicology screening at early stages of drug discovery and development process has become even more imperative.

Join us at SMi's 11th annual ADMET taking place on the 13th - 14th June 2016 in London. This event will explore novel and emerging
non- clinical ADME approaches, structure based prediction of ADME properties, PK/PD modeling to validate drug targets and toxicity and many more.

For more info visit:

SMi's 5th annual ADC Summit provides a comprehensive analysis of the various approaches with the next generation ADCs. Hear the latest insights from Takeda on Adcetris; discuss the latest advancements in research and development from Medimmune; and analyse case studies from big pharma companies such as Roche, Bayer, Pfizer, AstraZeneca, Novartis and many more.

Join industry experts as they share, confer and debate how to create the next wave of ADCs with better efficacy, lower toxicity and improved potency for clinical success.

Register for 2 half-day post-conference workshops

WORKSHOP A: ADC Payloads: Availability and Mechanisms of Action hosted by Femtogenix and King’s College London

WORKSHOP B: Developments in High Potency Manufacturing hosted by SKAN AG

For more information or to register visit

Registration is now live to attend the 10th annual Clinical Trial Logistics conference taking place in London on 18th & 19th May 2016.

The implementation of Annex 15 of the Good Manufacturing Practice in Autumn 2015 provided a huge change in the regulatory landscape of the rapidly growing clinical trial supplies industry, with logistics and distribution services accounting for the largest share of the market.

Clinical Trial Logistics 2016 will bring together leading industry professionals to discuss the latest regulatory developments, explore cost reduction, learn about logistical challenges in emerging markets, examine new innovations and examine best practices to ensure compliance of the new EU Clinical Trials Regulation which affects all parties in the clinical supply chain.


* Gain key regulatory updated from Daiichi Sankyo and MHRA talking specifically on the development of the New EU Clinical Trials Regulation

* Discuss how to integrate forecasting and supply planning to an efficient clinical supply chain from GlaxoSmithKline

* Norgine presents how they ensure and maintain a successful contractor relationship

* Engage in discussions with Sanofi on visibility in the supply chain to fight counterfeiting


* Graham McNaughton, Pharmaceutical Assessor, MHRA

* Elisabetta Carli, Head, Operations Clinical Vaccines Management, GlaxoSmithKline

* Tony Moult, Director, Clinical Supplies Ooperations, Daiichi Sankyo

* Geoffroy Bessaud, AVP, Anti-Counterfeiting Coordination, Sanofi

* Dawn Padfield, Director of Pharmaceutical Development and Clinical Supply, Norgine

* Elodie Fontaine, Clinical Trial Lead, Lundbeck

* Jasmine Hellwig, Senior Comparator Specialist, Merck Sharpe and Dohme

* Abdulkareem Ghanayem, Clinical Trial Operations Project Manager, Takeda


Book by 29th February to save £400 and benefit from the best price.

Register online here.

More Articles...

Page 4 of 36

FacebookMySpaceTwitterDiggDeliciousStumbleuponGoogle BookmarksRedditNewsvineTechnoratiLinkedinMixxRSS Feed